Community pharmacy and pharmacist staff call center: Assessment of medication safety and effectiveness

Lisa Higgins, Mary Brown, John E Murphy, Daniel C Malone, Edward P Armstrong, Raymond L. Woosley

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Objective: To determine proof of concept for use of a network of pharmacists to evaluate the safety of medications. Design: Pilot, comparative, prospective evaluation. Setting: Community pharmacies and a pharmacist-staffed call center in Arizona during January through August 2006. Patients: Patients filling prescriptions for ipratropium or tiotropium bromide at 1 of 55 Arizona pharmacies were encouraged to call a pharmacist-staffed call center. A total of 67 patients contacted the center and 41 participated. Intervention: A network of community pharmacies and a call center were used to collect data on patients receiving one of two medications for the treatment of chronic obstructive pulmonary disease. Pharmacists in the community pharmacies recruited patients who presented with a prescription or requested a refill for one of the medications. The call center was used to collect patient data. Patients provided data on medication use, completed the chronic respiratory questionnaire (CRQ), and were encouraged to call the center to report health problems. After 30 days, patients were called to determine whether they experienced any adverse events while taking their medication and the CRQ was readministered. Main outcome measure: Knowledge gained on the feasibility of the model using pharmacists to assess drug safety. Results: A total of 67 (6.7%) of a possible 995 patients contacted the call center about participating in the study. Approximately one-half (n = 28) of the 55 pharmacies had one or more patients contact the center about the study. A total of 41 patients met inclusion/exclusion criteria and were enrolled. Six (15%) patients reported an adverse effect, including one serious adverse event (acute glaucoma). Conclusion: This study provides limited evidence that community pharmacies and a pharmacist-staffed call center can be used to assess medication safety; however, a number of issues need to be examined to determine whether the approaches can be sufficiently effective.

Original languageEnglish (US)
Pages (from-to)82-89
Number of pages8
JournalJournal of the American Pharmacists Association
Volume51
Issue number1
DOIs
StatePublished - 2011

Fingerprint

Pharmacies
Pharmacists
Safety
Ipratropium
Pulmonary diseases
Medical problems
Pharmaceutical Preparations
Prescriptions
Call Centers
Glaucoma
Chronic Obstructive Pulmonary Disease
Outcome Assessment (Health Care)

Keywords

  • Adverse drug effects
  • Community pharmacy
  • Pharmacovigilance
  • Safety

ASJC Scopus subject areas

  • Pharmacy
  • Pharmacology
  • Pharmacology (nursing)
  • Medicine(all)

Cite this

Community pharmacy and pharmacist staff call center : Assessment of medication safety and effectiveness. / Higgins, Lisa; Brown, Mary; Murphy, John E; Malone, Daniel C; Armstrong, Edward P; Woosley, Raymond L.

In: Journal of the American Pharmacists Association, Vol. 51, No. 1, 2011, p. 82-89.

Research output: Contribution to journalArticle

@article{1c7c847f6fc04838821b8288a4a3bf82,
title = "Community pharmacy and pharmacist staff call center: Assessment of medication safety and effectiveness",
abstract = "Objective: To determine proof of concept for use of a network of pharmacists to evaluate the safety of medications. Design: Pilot, comparative, prospective evaluation. Setting: Community pharmacies and a pharmacist-staffed call center in Arizona during January through August 2006. Patients: Patients filling prescriptions for ipratropium or tiotropium bromide at 1 of 55 Arizona pharmacies were encouraged to call a pharmacist-staffed call center. A total of 67 patients contacted the center and 41 participated. Intervention: A network of community pharmacies and a call center were used to collect data on patients receiving one of two medications for the treatment of chronic obstructive pulmonary disease. Pharmacists in the community pharmacies recruited patients who presented with a prescription or requested a refill for one of the medications. The call center was used to collect patient data. Patients provided data on medication use, completed the chronic respiratory questionnaire (CRQ), and were encouraged to call the center to report health problems. After 30 days, patients were called to determine whether they experienced any adverse events while taking their medication and the CRQ was readministered. Main outcome measure: Knowledge gained on the feasibility of the model using pharmacists to assess drug safety. Results: A total of 67 (6.7{\%}) of a possible 995 patients contacted the call center about participating in the study. Approximately one-half (n = 28) of the 55 pharmacies had one or more patients contact the center about the study. A total of 41 patients met inclusion/exclusion criteria and were enrolled. Six (15{\%}) patients reported an adverse effect, including one serious adverse event (acute glaucoma). Conclusion: This study provides limited evidence that community pharmacies and a pharmacist-staffed call center can be used to assess medication safety; however, a number of issues need to be examined to determine whether the approaches can be sufficiently effective.",
keywords = "Adverse drug effects, Community pharmacy, Pharmacovigilance, Safety",
author = "Lisa Higgins and Mary Brown and Murphy, {John E} and Malone, {Daniel C} and Armstrong, {Edward P} and Woosley, {Raymond L.}",
year = "2011",
doi = "10.1331/JAPhA.2011.09108",
language = "English (US)",
volume = "51",
pages = "82--89",
journal = "Journal of the American Pharmacists Association : JAPhA",
issn = "1544-3191",
publisher = "American Pharmacists Association",
number = "1",

}

TY - JOUR

T1 - Community pharmacy and pharmacist staff call center

T2 - Assessment of medication safety and effectiveness

AU - Higgins, Lisa

AU - Brown, Mary

AU - Murphy, John E

AU - Malone, Daniel C

AU - Armstrong, Edward P

AU - Woosley, Raymond L.

PY - 2011

Y1 - 2011

N2 - Objective: To determine proof of concept for use of a network of pharmacists to evaluate the safety of medications. Design: Pilot, comparative, prospective evaluation. Setting: Community pharmacies and a pharmacist-staffed call center in Arizona during January through August 2006. Patients: Patients filling prescriptions for ipratropium or tiotropium bromide at 1 of 55 Arizona pharmacies were encouraged to call a pharmacist-staffed call center. A total of 67 patients contacted the center and 41 participated. Intervention: A network of community pharmacies and a call center were used to collect data on patients receiving one of two medications for the treatment of chronic obstructive pulmonary disease. Pharmacists in the community pharmacies recruited patients who presented with a prescription or requested a refill for one of the medications. The call center was used to collect patient data. Patients provided data on medication use, completed the chronic respiratory questionnaire (CRQ), and were encouraged to call the center to report health problems. After 30 days, patients were called to determine whether they experienced any adverse events while taking their medication and the CRQ was readministered. Main outcome measure: Knowledge gained on the feasibility of the model using pharmacists to assess drug safety. Results: A total of 67 (6.7%) of a possible 995 patients contacted the call center about participating in the study. Approximately one-half (n = 28) of the 55 pharmacies had one or more patients contact the center about the study. A total of 41 patients met inclusion/exclusion criteria and were enrolled. Six (15%) patients reported an adverse effect, including one serious adverse event (acute glaucoma). Conclusion: This study provides limited evidence that community pharmacies and a pharmacist-staffed call center can be used to assess medication safety; however, a number of issues need to be examined to determine whether the approaches can be sufficiently effective.

AB - Objective: To determine proof of concept for use of a network of pharmacists to evaluate the safety of medications. Design: Pilot, comparative, prospective evaluation. Setting: Community pharmacies and a pharmacist-staffed call center in Arizona during January through August 2006. Patients: Patients filling prescriptions for ipratropium or tiotropium bromide at 1 of 55 Arizona pharmacies were encouraged to call a pharmacist-staffed call center. A total of 67 patients contacted the center and 41 participated. Intervention: A network of community pharmacies and a call center were used to collect data on patients receiving one of two medications for the treatment of chronic obstructive pulmonary disease. Pharmacists in the community pharmacies recruited patients who presented with a prescription or requested a refill for one of the medications. The call center was used to collect patient data. Patients provided data on medication use, completed the chronic respiratory questionnaire (CRQ), and were encouraged to call the center to report health problems. After 30 days, patients were called to determine whether they experienced any adverse events while taking their medication and the CRQ was readministered. Main outcome measure: Knowledge gained on the feasibility of the model using pharmacists to assess drug safety. Results: A total of 67 (6.7%) of a possible 995 patients contacted the call center about participating in the study. Approximately one-half (n = 28) of the 55 pharmacies had one or more patients contact the center about the study. A total of 41 patients met inclusion/exclusion criteria and were enrolled. Six (15%) patients reported an adverse effect, including one serious adverse event (acute glaucoma). Conclusion: This study provides limited evidence that community pharmacies and a pharmacist-staffed call center can be used to assess medication safety; however, a number of issues need to be examined to determine whether the approaches can be sufficiently effective.

KW - Adverse drug effects

KW - Community pharmacy

KW - Pharmacovigilance

KW - Safety

UR - http://www.scopus.com/inward/record.url?scp=79955930457&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79955930457&partnerID=8YFLogxK

U2 - 10.1331/JAPhA.2011.09108

DO - 10.1331/JAPhA.2011.09108

M3 - Article

C2 - 21247830

AN - SCOPUS:79955930457

VL - 51

SP - 82

EP - 89

JO - Journal of the American Pharmacists Association : JAPhA

JF - Journal of the American Pharmacists Association : JAPhA

SN - 1544-3191

IS - 1

ER -